Tweet By Jeff Pierce ALIM is a biopharmaceutical company engaged in the R&D and commercialization of prescription ophthalmic pharmaceuticals. It’s about ready to break out to new 2014 highs as soon as tomorrow and you can see that volume is definitely supporting each of the big moves higher. ALIM IPO’d in 2010 above $11 and […]